Skip to main content

The Center for AIDS Research and Treatment (CART)

CART is the largest provider of HIV care in the Long Island region and serves 2,200 PLWH (people living with HIV/AIDS) over the past two years. CART has been a New York State Department of Health AIDS Institute Designated AIDS Center (DAC) since 1988. CART has achieved recognition as a Level 3 Patient Centered Medical Home for HIV by the NCQA and serves an ethnically and racially diverse urban and suburban population, including a sizeable number of immigrant and migrant clients. Each patient in CART is assigned an HIV expert clinician (either an infectious diseases specialist or a nurse practitioner who is credentialed as an HIV specialist by the American Academy of HIV Medicine), an RN case manager and a social worker as part of a multidisciplinary care team.

Travel and Immunization Center

Our travelers' advice and immunization practices specialize in the care of the routine adult traveler, as well as care of the long-term, high-risk, specialty, immunocompromised or pregnant traveler. We provide consultations in travel medicine and immunizations.

Transplant infectious diseases

The Transplantation Infectious Disease and Compromised Host Program provides care to solid organ, bone marrow and stem cell transplant recipients. We monitor and control infections, helping patients to achieve optimal outcomes.


The Infectious Disease Center provides the highest level of multidisciplinary care to patients living with mycobacterial diseases, including tuberculosis (TB), non-tuberculous mycobacteria (NTM), mycobacterium avium complex (MAC) and Hansen’s disease.

General infectious diseases

Our division provides diagnosis, treatment and care of individuals with any sort of infection. We have 17 full-time and three voluntary physicians, as well as two nurse practitioners, each with different areas of specialty to best serve our patients’ needs.

Cardiovascular infections

Our division works closely with the cardiology, vascular and cardiothoracic surgery divisions of Northwell Health to manage all types of cardiovascular infections. Our faculty provides support for the Comprehensive Cardiovascular Program, which includes implantation of left ventricular assist devices (LVAD). 

Clostridium difficile

Dr. Bruce Hirsch leads the faculty in innovative approaches to treatment of clostridium difficile and was a pioneer in providing oral fecal transplants for patients suffering from recurrent clostridium difficile.

Inpatient consultative services

Our division provides 24/7 consultations for hospitalized patients. Our faculty provides over 3,000 consultations each year supporting the numerous medical, surgical, obstetrical and emergency programs at North Shore University Hospital and Long Island Jewish Medical Center.


The division has an on-site pharmacy dedicated to infectious diseases and a doctor of pharmacy present to provide consultative services to patients.

Infection prevention

We direct the Infection Prevention Program for both North Shore University Hospital and Long Island Jewish Medical Center. We are also involved in many of the preventive policies that are used for the entire organization. We have eight full-time infection prevention staff members, a computerized surveillance system, and we interact with local and state departments of health frequently. The program has dramatically cut the rates of clostridium difficile infection in our community and takes a multidisciplinary approach to MRSA and clostridium difficile control.

Antimicrobial stewardship

We run a comprehensive Antimicrobial Stewardship Program. We utilize a retrospective review and feedback of antimicrobial use to guide clinicians in our institutions. The goal of this program is to educate clinicians regarding appropriate utilization and prevention of overuse of antimicrobials as well as guidance on duration of therapy. The program is involved in the development of guidelines for most common infectious syndromes. Through collaboration with the Infection Prevention Program, this program aims to reduce rates of antimicrobial resistance and clostridium difficile infection.

Go to top